Nearly six months on from testing positive for the banned substance Letrozole and being suspended by Canyon-Sram, Shari Bossuyt is still dumbfounded as to how the drug entered her system and believes her Paris Olympics dreams are over.
Bossuyt tested positive for Letrozole, which is primarily used to treat estrogen-sensitive cancer in post-menopausal women, on March 19 at the Tour de Normandie before her team were notified and placed her on a ‘provisionally non-active’ status in June.
